«
MAPS-2 site
MAPS-2 trial
M
etoclopramide for
A
voiding
P
neumonia after
S
troke 2
Trial documents
Emergency numbers
This page does not provide the emergency mobile numbers.
Please
log in
to view them, or bookmark the main documents page instead of this one.
Approved protocol
» Please
click here
to view superseded documents
Research Protocol v 2.0 20240702 - clean.pdf
Trial documents
Awareness Poster 20240603 v3.0.pdf
Eligibility Checklist v1.0 20230427.pdf
File Note Template.docx
Transfer Form 20221124 v1.0.pdf
Treatment Administration Instructions 20220506 v1.0.docx
Trial Contact Sheet - updated 27.08.2024.pdf
UKCRN letter of Portfolio acceptance 13.10.21.pdf
Site training
» Please
click here
to view superseded documents
Blank Training Log.doc
SIV Training Slides 20240902 V9.0.pdf
Videos
Alternative IMP Delivery 20220104 v1.0.mp4
Metoclompramide NG Administration 20220104 v1.0.mp4
REDCap Demo 20211118 v1.0.mp4
Information sheets and consent forms
GP letter Final including ref nos. 20210611 v1.0.docx
Legal Representative Consent Form Final v1.0 20211108.docx
Legal Representative Information Sheet Final v1.0 20211108.docx
Legal Representative Information and Consent Form Final v1.0 20211108.docx
Legal Representative Telephone Consent Form Final v1.0 20211108.docx
Participant Consent Form Final v1.0 20211108.docx
Participant Information Sheet Final v1.0 20211108.docx
Participant Information and Consent Form Final v1.0 20211108.docx
Participant Re-consent Final 1.0 20211108.docx
Pharmacy documents
Metoclopramide 5 mg ml Injection - Summary of Product Characteristics (SmPC) - print friendly - (emc).pdf
Sponsor
documents
» Please
click here
to view superseded documents
Evidence of Cover Clinical Trials Insurance 01.08.2024 - 31.07.2025.pdf
SOP TA008 Trial Initiation 20190128 V3.5.pdf
SOP TA010 TMF TSF 20180205 V2.0.pdf
SOP TA016 SeriousGCPBreachReporting 20180112 V1.5.pdf
REC documents
(290474) 21.EM.0246 Favourable Opinion on further information 20211117.pdf
MHRA documents
CTA Acknowledgement Administration Letter SA01 20230802.pdf
CTA Notice of Acceptance 20211022.pdf
Cover Letter MHRA signed CR 190821.docx
IRAS290474 Letter of HRA Approval 20211117.pdf
Substantial amendments
»
SA-03-24
/
Minor amendments
MA-21-24
/
MA-20-24
/
MA-19-24
/
MA-18-24
/
MA-17-24
/
MA-16-23
/
MA-15-23
/
MA-14-23
/
MA-13-23
/
MA-12-23
/
MA-11-23
/
MA-10-22
/
MA-09-22
/
MA-08-22
/
MA-07-22
/
MA-06-22
/
MA-05-22
/
MA-04-22
/
MA-03-22
/
MA-02-22
/
MA-01-21
/
Trial working practice documents
221012 MAPS-2 Consent hierarchy flow chart.pdf
Database access WPD 20220421 v1.0.pdf
Newsletters
Newsflash2 MARCH 2023 recruitment window changed to 24 hours.pdf
Newsflash MARCH 2023 who can prescribe.pdf
Newsletter - AUG 2022.pdf
Newsletter - FEBRUARY 2023.pdf
Newsletter - JUNE 2022.pdf
Newsletter APRIL 2024.pdf.pdf
Newsletter December 2024.pdf
(updated 5 days ago)
Newsletter JULY 2024.pdf
Newsletter JUNE 2024.pdf
Newsletter May 2024.pdf.pdf
Newsletter November 2024.pdf
(updated 5 days ago)
Newsletter OCTOBER 2024.pdf
Investigator meetings
Investigator Meeting 20240628.pdf
Investigator Meeting 20240924.pdf
Investigator Meeting Slides 20240726.pdf
Printable CRFs
See also:
list of recent changes
.
(updated 186 days ago)
Randomisation
v1.5
Daily clinical monitoring log
v1.2
Results of cultures
v1.1
Antibiotic treatment
v1.1
Day 14 follow-up
v2.3
Pneumonia diagnosis
v1.1
Discharge to the community
v1.1
Vital status
v1.1
Serious Adverse Event
v1.4
Protocol violation
v1.2
Withdrawal notification
v1.0
Site-to-site transfer
v1.1
Please log in to download a zip archive of printable CRFs from the supporting site.
Participant contact details should be submitted directly online.
A printable preview of the contact details form is available
here
.
To read PDF documents, you may need to install Acrobat Reader first. Please
click here
if you require installation instructions.
Switch to desktop site
